News from pfenex inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NYSE:AZN,Bloomberg:AZN@LN,Bloomberg:AZN@US,LSE:AZN,RICS:AZN.N)

Dec 16, 2015, 06:45 ET
Pfenex logo

Selling Shareholder Prices Secondary Offering

 Pfenex Inc. (NYSE MKT: PFNX) announced today the pricing of its secondary offering of 600,000 shares of its common stock at a price to the...

Dec 15, 2015, 16:41 ET
Pfenex logo

Selling Shareholder Launches Proposed Secondary Offering

Pfenex Inc. (NYSE MKT: PFNX) announced today the launch of a proposed secondary public offering of 600,000 shares of its common stock. All of such...

Nov 13, 2015, 08:00 ET
Pfenex logo

Pfenex Reports Third Quarter 2015 Results and Provides Business Update

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high value...

Oct 27, 2015, 08:30 ET
Pfenex logo

Pfenex To Report Third Quarter 2015 Results and Provide Business Update on Friday, November 13, 2015

Pfenex Inc. (NYSE MKT: PFNX) announced today that its third quarter 2015 financial results will be released on Friday, November 13, 2015, before...

Sep 15, 2015, 08:30 ET
Pfenex logo

Pfenex Announces Appointment Of Dennis Fenton To Board Of Directors

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biosimilars company, announced today that Dennis M. Fenton, Ph.D., has been appointed to the...

Sep 11, 2015, 08:30 ET
Pfenex logo

Pfenex to Present at the Morgan Stanley Healthcare Conference

Pfenex Inc. (NYSE MKT: PFNX) announced today that Bertrand C. Liang, chief executive officer of Pfenex will be presenting at the Morgan Stanley...

Aug 17, 2015, 08:00 ET
Pfenex logo

Pfenex Inc. Awarded HHS Contract Valued At Up To $143.5 Million For The Advanced Development Of Next Generation Anthrax Vaccine

Pfenex Inc. (NYSE MKT: PFNX), announced today it has signed a five year, cost plus fixed fee contract valued at up to $143.5 million with the...

Aug 13, 2015, 07:45 ET
Pfenex logo

Pfenex Reports Second Quarter 2015 Results and Provides Business Update

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high...

Jul 29, 2015, 08:30 ET
Pfenex logo

Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015

 Pfenex Inc. (NYSE MKT: PFNX) announced today that its second quarter 2015 financial results will be released on Thursday, August 13, 2015,...

Jun 16, 2015, 08:00 ET
Pfenex logo

Pfenex To Present at the JMP Securities Life Sciences Conference 2015

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high value and...

May 14, 2015, 08:00 ET
Pfenex logo

Pfenex Reports First Quarter 2015 Results and Provides Business Update

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, including high...

May 01, 2015, 08:30 ET
Pfenex logo

Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high value and...

Apr 30, 2015, 08:30 ET
Pfenex logo

Pfenex Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

 Pfenex Inc. (NYSE MKT: PFNX) a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high value...

Apr 28, 2015, 08:30 ET
Pfenex logo

Pfenex Announces Election of John Taylor to its Board of Directors

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics and high-value and...

Apr 24, 2015, 08:30 ET
Pfenex logo

Pfenex Inc. Announces Pricing Of Follow-on Offering

 Pfenex Inc. (NYSE MKT: PFNX) a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high value...

Mar 23, 2015, 09:00 ET
Pfenex logo

Pfenex Announces Early HSR Clearance for Collaboration with Hospira

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high...

Mar 16, 2015, 08:30 ET
Pfenex logo

Pfenex Reports Fourth Quarter and Full Year 2014 Results and Provides Business Update

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high value and...

Mar 05, 2015, 17:00 ET
Pfenex logo

Pfenex To Report Fourth Quarter and Full Year 2014 Results and Provide Business Update

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high...

Mar 02, 2015, 08:30 ET
Pfenex logo

Pfenex to Present at the 2015 Barclays Global Healthcare Conference

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, today announced...

Feb 27, 2015, 08:00 ET
Pfenex logo

Pfenex to Present at CALBIO 2015

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, today announced...